298 CHAPTER 4.1 Declarations Authors’ contributions Authorship eligibility is based on the ICMJE authorship criteria. The authors certify that they have participated in the aspects conception and design (BS, CH, TE, EvP, DOM, AS, NR, IW, WK), acquisition and interpretation of data (BS, CH, JoH, IS, TE, EvP, IW, WK, NR, AS, DOM), drafting the article (BS, CH) and revising it critically for important intellectual content (all authors). All authors have approved the final article. We have not received substantial contributions from non-authors. Competing interests DOM has a patent A Prescription Decision Support System (based on screening tool of older person’s prescriptions and screening tool to alert to the right treatment (STOPP/START) prescribing rules) issued to European Patent Office (Munich). MS reports a 2011 grant and personal fees from Spru IT, before the conduct of the study; in addition, MS reports a settlement agreement between Spru IT and Utrecht University, in which all systematic tool to reduce inappropriate prescribing (STRIP) assistant IP is transferred to Utrecht University, in exchange for obtaining a free but non-exclusive right to provide STRIP assistant consultancy or support services, or both on a commercial basis, and to update the STRIP assistant, until June 2023. Data availability statement Data for this study will be made available to others in the scientific community upon request after publication. Data will be made available for scientific purposes for researchers whose proposed use of the data has been approved by a publication committee. Ethics approval The OPERAM trial was approved by the independent research ethics committees at each participating site (lead ethics committee: Cantonal Ethics Committee Bern, Switzerland, ID 2016-01200; Medical Research Ethics Committee Utrecht, Netherlands, ID 15-522/D; Comité d’Ethique Hospitalo-Facultaire Saint-LucUCL: 2016/20JUL/347–Belgian registration No: B403201629175; Cork University Teaching Hospitals Clinical Ethics Committee, Cork, Republic of Ireland; ID ECM 4 (o) 07/02/17), and Swissmedic as responsible regulatory authority.
RkJQdWJsaXNoZXIy MTk4NDMw